C1 esterase inhibitor (Chengdu Institute of Biological Products)

C1酯酶抑制剂(成都生物制品研究所)

Report date: 2023/12/18 16:03:43

Base Information

Drug NameC1 esterase inhibitor (Chengdu Institute of Biological Products)
Drug Alias NameC1 esterase inhibitor重组人C1酯酶抑制剂
ClassificationBiologics > Blood components
Mechanisms of ActionSerine protease inhibitorsComplement C1s inhibitorsComplement C1r inhibitors
TargetsSerine proteaseComplement C1sComplement C1r
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A